Importantly, elevated circulating and urinary NGAL levels have been observed in the absence of overt signs of CKD (e.g., increased serum creatinine levels or decreased estimated glomerular filtration rate [eGFR]), rendering it a potentially attractive biomarker for pre-diagnostic CKD [10,13]. Here, LCN2 is linked to chronic kidney disease.